Digital Building an AI-native CRO Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.
R&D Trial complexity is the new normal When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
R&D When metrics measure more than they improve The question to ask is not, "Are we measuring site performance?" but, "Are the metrics we collect providing actionable insights early enough?"
R&D How automation can drive a competitive advantage for CROs & ... For CROs and CDMOs, automation is key to ensuring long-term success.
R&D Navigating the new ICH E6 (R3): Key changes for sponsors These new regulations for running clinical trials in the UK will be a legal requirement from 28th April 2026.
R&D A playbook for effective sponsor/CRO partnership Find out more about optimising sponsor/CRO collaboration in an interview on a case study in FI cell therapy.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
